Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-17

Clinical Trial Update: Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating add-on levetiracetam for myoclonic jerks in adolescents and adults with generalized convulsive epilepsy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Generalized Convulsive Epilepsy | Phase 3 | Status: COMPLETED